| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communications |
§
§
From the Department of Pathology,*
Uniformed Services
University of the Health Sciences, Bethesda, Maryland; the
Resuscitation Medicine Program,
Naval Medical
Research Institute, Bethesda, Maryland; Comparative
Pathology (HEDV),
Air Force Research
Laboratory, Brooks Air Force Base, Texas; and the Pathobiology
Division,§
Naval Medical Research Institute,
Bethesda, Maryland
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Our laboratory has been exploring orally administered cytokines, particularly interleukin-6 (IL-6), as agents to affect gut function. We have shown that IL-6, when given at the time of infection, can dramatically reduce the numbers of infectious Campylobacter organisms in the mouse.7 This reduction takes place well in advance of the onset of antigen-specific IgA in the intestinal secretions of infected mice. These data suggest that, in addition to its traditional role in augmenting B cell responses, IL-6 has additional, not yet described, effects on the intestinal mucosa.
Further examination of the role of IL-6 in intestinal function has shown that it is instrumental in the reduction or elimination of bacterial translocation after hemorrhagic shock in mice8 and rats.9 Because IL-6 has been shown to be a vasorelaxer,8,10 we postulated that its role in the prevention of gut injury following hemorrhage is dependent on its ability to increase intestinal circulation, thereby decreasing the total ischemia time and allowing for nearly full recovery of the intestine after hemorrhage.
| Materials and Methods |
|---|
|
|
|---|
BALB/CByJ female mice were obtained from The Jackson Laboratory (Bar Harbor, ME). They were certified pathogen-free, and screening by Charles River Testing Services (Portage, MI) showed no serological evidence of viral or parasitic infection. Mice were housed in AAALAC-approved laminar flow cages in animal facilities at the Naval Medical Research Institute (Bethesda, MD). Standard laboratory animal chow and water were provided ad libitum.
Hemorrhagic Shock Model
The hemorrhagic shock model used has been described previously.8 Briefly, nonfasted, anesthetized mice were cannulated in both femoral arteries to measure blood pressure in one and to bleed from the other. Mice were bled to and maintained at a mean arterial pressure of 35 mm Hg for 1 hour and then resuscitated (over 15 minutes) with shed blood and a twofold volume of lactated Ringers solution. After regaining consciousness, 30 minutes after resuscitation, they were fed 0.5 ml phosphate-buffered saline vehicle alone or vehicle containing 300 units rIL-6 (Genzyme, Boston, MA). After overnight recovery (16 hours), the mice were prepared for horseradish peroxidase (HRP) and bacterial translocation studies as described below.
HRP label, mol wt 40 kd, was prepared as a solution of 4 mg in 0.25 ml 0.9% NaCl.11 In the HRP iv groups, the label was injected into the tail vein, and 10 minutes later the mice were sacrificed by cervical dislocation under methoxyfluorane anesthesia. In the HRP il groups, it was injected into a ligated loop of distal ileum and allowed to penetrate the mucosa for 15 minutes in methoxyfluorane-anesthetized mice before sacrifice.1,3 For each experiment, three mice were used: one for hemorrhage plus IL-6, one for hemorrhage plus vehicle, and one for sham. The bacterial translocation experiments were repeated at least 50 times. The HRP experiments were performed 6 times.
Bacterial Translocation
Enumeration of bacteria in solid organs has been published previously.8 Briefly, tissues were removed from mice, weighed, and homogenized in 4 ml phosphate-buffered saline. Serial dilutions of the homogenate were plated on sheep blood agar plates and incubated at 37°C for 24 to 48 hours. Bacterial colonies were counted and calculated as colonies per gram of tissue.
Histology
The ileum of each mouse was removed immediately, flushed, cut into 0.5-cm rings, and fixed in 2% glutaraldehyde, 1% paraformaldehyde in 0.1 mol/L sodium cacodylate buffer, pH 7.25, for 1 hour at 4°C. All of the intestines were rinsed overnight at 4°C in 0.1 mol/L sodium cacodylate buffer, pH 7.5. Sections of intestinal rings 100 mm thick were cut for localization of label. Demonstration of peroxidase location was achieved by incubating the sections in the dark for 20 minutes in 5 ml DAB (3, 3'-diaminobenzidine) substrate medium (Sigma Immuno Chemicals, St. Louis, MO). Sections were then rinsed in Tris(hydroxymethyl)aminomethane buffer and postfixed in 1% sodium cacodylate buffered osmium tetroxide for 60 minutes. After dehydration with ethanol, the sections were treated with propylene oxide and embedded in Epon polybed 812 (Poly/Bed; Polysciences, Warrington, PA). Sections 1 mm thick were examined by light microscopy. Ultrathin sections prepared with a diamond knife were lightly stained with lead citrate and examined in a JEOL 100 CXII electron microscope (JEOL, Peabody, MA).
| Results |
|---|
|
|
|---|
The effect of hemorrhage on intestinal circulation can be seen very
clearly in mice receiving an iv injection of HRP. In normal,
unhemorrhaged mice, the HRP is seen to pass between intestinal
epithelial cells from the circulation to the lumen (arrows, Figure 1A
)
suggesting that the
intestinal circulation is patent, allowing the label to reach the
intestinal lumen by intravascular pressure. Vesicles containing HRP are
also present in the cytoplasm as has been previously
noted.12
|
When mice were given HRP il, the distribution pattern is opposite that
seen in mice injected iv. In normal mice, HRP penetrated from the lumen
only as far as the zonula occludens suggesting that the intestinal
barrier function was well maintained (Figure 2A)
. Bacterial products,
to the extent that they are the size of HRP, cannot penetrate past the
zonula occludens. Large amounts of HRP are seen between intestinal
epithelial cells only in mice hemorrhaged and fed vehicle (Figure 2B)
.
The prominent cytoplasmic vacuoles and swelling of mitochondria seen in
epithelial cells of shocked mice fed vehicle are indicative of cell
degeneration. Intestines of mice hemorrhaged and fed IL-6, although not
completely normal, show a reduced pattern of HRP distribution,
suggesting the reestablishment of barrier function (Figure 2C)
.
|
|
| Discussion |
|---|
|
|
|---|
Although IL-6 might be thought to be limited in availability by stomach
and intestinal digestive processes, it has been shown to be
extraordinarily resistant to acid denaturation and proteolysis by its
unique structure and glycosylation. It has been shown that mutant IL-6
adopts a molten globule structure in an acid environment and, while in
that configuration, is resistant to proteolysis.15
Similarly, the cytokine granulocyte-colony stimulating factor (G-CSF)
is capable of assuming this same kind of molten globule structure in an
acid environment.16
It has been postulated that cytokines
of the 4-
chain amino acid class, which includes IL-6 and G-CSF, are
all similarly resistant to acid proteolysis (deFellipis, personal
communication). Inasmuch as intestinal epithelial cells express IL-6R
on their lumenal surfaces17
(F. M. Rollwagen,
unpublished data), it can be supposed that IL-6 survives passage
through the stomach and proximal small intestine to maintain its
functions in the ileum.
This report demonstrates that the intestinal barrier is compromised
after hemorrhage, suggesting a mode of transport by which
lipopolysaccharide and perhaps live bacteria can move freely
from the lumen between intestinal epithelial cells into the sterile
interior. HRP administered to normal mice seems to travel from the
blood vessels to the lumen of the intestine. The route of transport
appears to flow between intestinal epithelial cells, despite the
presence of tight junctions, rather than being transported through the
cells. This particular route of travel not only establishes a positive
pressure gradient which may prevent backflow of intestinal contents
between cells, it also is a marker of vascular patency, in that
the label can travel through the vasculature to reach the epithelium.
Evidence for this positive flow is seen in Figure 1A
, and has been
shown in rats by Andersen et al.18
In shocked mice fed
saline (Figure 1B)
, the label is prevented from reaching the lumen,
perhaps because vascular spasm reduced blood flow to the area. The
subsequent loss of blood flow to the intestinal microvasculature
reverses this positive pressure gradient leading to retrograde flow
from the lumen between intestinal epithelial cells and into the
systemic circulation (Figure 2B)
. These results may explain the
existence of sepsis syndrome in trauma patients who lack a focus of
infection.4
After IL-6 administration, HRP administered iv
is again present between the epithelial cells (Figure 1C)
. Restoration
of intestinal blood flow, shown by the data of this group of mice,
suggests that orally administered IL-6 allows blood flow to return to
the intestine after hemorrhage. Similarly, passage of HRP from the
lumen was blocked at the zonula occludens in normal mice (Figure 2A)
and in those hemorrhaged and fed IL-6 (Figure 2C)
. These data support
the work of Langer et al,14
who showed that intralumenally
administered HRP can permeate between the intestinal epithelia of
shocked animals, and extend it to show our IL-6 effects. Prevention of
the passage of intralumenally administered HRP at the zonula occludens
also supports the work of Rhodes and Karnovsky,19
who
first demonstrated this secondary barrier function.
It has been suggested that IL-6 produced by intraepithelial lymphocytes
is responsible for the loss of intestinal barrier function following
hemorrhage, and the extent of loss can be correlated with plasma levels
of this cytokine.20
Since it has been shown that cytokines
such as tumor necrosis factor,21
IL-1,22
interferon-
,23
and IL-622
can be secreted
by epithelial cells in culture, and may affect epithelial cell
function,24
attributing the intestinal cytokine source to
intraepithelial lymphocytes alone may be limiting. IL-6 alone may not
be solely responsible for the deleterious effects of
hypoxia/reoxygenation on the gut, since levels of other inflammatory
cytokines also play an important role in loss of barrier function.
Correlation of intestinal damage with measurement of serum cytokine
levels by enzyme-linked immunosorbent assay25,26
or
bioassay27,28
may also be ambiguous, because the presence
of soluble cytokine receptor (especially IL-6R) and other cytokine
carrier proteins (known as chaperones25
) may compromise
the results.27,28
Finally, the correlation between levels
of a single cytokine in serum and mucosal permeability is limiting,
because it is known that cytokines are seldom secreted singly and are
usually found as part of a spectrum of inflammation.
Although it has been difficult to show bacterial translocation in clinical cases, patients suffering from hemorrhagic shock or post-surgical syndrome are quite prone to endotoxemia and multiple organ failure.29 These patients almost assuredly become endotoxemic from intestinal leakage, even though a peripheral focus of bacteremia is not found. Endotoxin administered iv can induce intestinal damage, as evidenced by the presence of increased intestinal hemoglobin and other serum proteins.30 It is possible, therefore, that once a small amount of intestinal damage is sustained by focal lesions after hemorrhage, the response can be self-stimulating, in that the small amounts of endotoxin released can induce further epithelial damage.31 Such damage can result in a reduction in net ion transport across the epithelium,32 leading to further metabolic impairment.
The data of this communication suggest that oral IL-6 administration partially restores the positive pressure gradient seen in normal mice and establishes a barrier to the migration of bacteria and their products into the circulation. The establishment of such a gradient could be brought about by any number of physiological changes induced by IL-6, such as increase in local blood pressure via relaxation of upstream blood vessels, constriction of downstream blood vessels, which would slow blood outflow, or an effect on lymphatic drainage. Our work8 and that of Ohkawa et al10 suggest that IL-6 acts as a vasorelaxer in the intestine, allowing more blood to flow into previously constricted vessels,2 leading to improved intestinal mucosal pH.32
The data presented in this report, as well as our previously published work, clearly show that orally administered IL-6 can be of benefit in the restoration of intestinal health after hemorrhage. We have shown that IL-6 reduces hypoxia-induced apoptosis in vivo and in vitro, most likely by increasing bcl-2 gene expression.5 These apoptosis findings support the work of Ikeda,33 who showed that apoptosis is induced in rat intestinal epithelium after hemorrhage. The hypoxia-induced apoptosis may be eliminated by a reduction in total ischemic time in vivo. If oral IL-6 restores intestinal perfusion, a theory supported by the work of others,32 then the reduced ischemia time of tissue may also reduce the apoptosis seen in hemorrhaged mice. It seems that orally administered IL-6 is of benefit in the restoration of intestinal health through its vasoactivity and its effects on hypoxia-induced apoptosis.
| Acknowledgements |
|---|
The experiments reported herein were conducted according to the principles set forth in the current edition of the Guide for Care and Use of Laboratory Animals. Institute for Laboratory Animal Resources, National Research Council, DHHS Publication No. (NIH) 8623.
The opinions and assertions contained herein are not to be construed as official or as reflecting the views of the Department of the Navy or the naval service at large.
| Footnotes |
|---|
Funded by Naval Medical Research and Development Command DC DD 1498 No. 61153N.MR04120.001.1470.
Accepted for publication January 6, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. K. Varghese Jr Invited commentary Ann. Thorac. Surg., August 1, 2006; 82(2): 478 - 479. [Full Text] [PDF] |
||||
![]() |
R. Yang, X. Han, T. Uchiyama, S. K. Watkins, A. Yaguchi, R. L. Delude, and M. P. Fink IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice Am J Physiol Gastrointest Liver Physiol, August 8, 2003; 285(3): G621 - G629. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |